Argus Research has increased its target price for pharmaceutical giant Novartis AG (NVS) to $170. This adjustment reflects a positive outlook on the company's future performance.
Argus Research Raises Novartis Price Target to $170
|1 min read
pharmaceutical stocksanalyst ratingprice targetstock upgradeinvestment research
